The Medical Technology Group has called for a new “Innovative Medical Devices Fund” in response to the latest £680m funding for innovative medicines.
The group that campaigns for better patient access to world-class medical technology on the NHS says earmarked funding for medical devices is urgently needed to help transform the health service and eliminate the backlog.
Barbara Harpham, MTG Chair: “Why isn’t there a scheme, similar to the Innovative Medicines Fund, to secure long-term investment in medical technology for the NHS? The MTG has long called for better funding for transformative medical device treatments, but there is still a funding gap to secure this on the NHS.
“Last September the government announced it would aim to provide £36billion over the next three years for innovation and new technologies to tackle the NHS waiting list crisis. We saw that plan continue to come to fruition this week with the latest funding round of £680m for the Innovative Medicines Fund. This is great news for patients on NHS waiting lists waiting for life-saving and life-enhancing treatment.
“We now need a similar Medical Device Fund for medical technology. Currently, there is no funding earmarked for medical technology adoption, which means patients are losing out on backlog reduction innovation that will enable world-class technology to diagnose, to treat and return them to normal life as quickly as possible.
“A medical devices fund that values long-term investment will help the government deliver on its ambitious plans to eliminate the backlog, improve the quality of care across the country and ensure NHS patients have fast and fair to the most pioneering medical technology in the world. world.”